Lianhua Qingwen explodes overseas


Novel coronavirus pneumonia is spreading worldwide. Following China’s ventilators, Chinese patent medicines, represented by Lianhua Qingwen, have become “hot commodities”.
Domestic to foreign, foreign fire to domestic
The novel coronavirus pneumonia is a new twenty day disposable medical mask, two KN95 respirators, two boxes of Lianhua Qingwen capsule, a package of medical disinfectant wipes, and a new crown pneumonia protection manual. Bai Yi, an overseas Chinese student, received a health package from the embassy a few days ago.
She told reporters that many students from other countries, envious of her, came to ask her what was in her health bag, and they also had to buy some.
It seems that the most special one is Lianhua Qingwen capsule. After the outbreak overseas, the Chinese medical expert team once carried Lianhua Qingwen to support Italy and other countries.
Bai said that novel coronavirus pneumonia symptoms appeared in some Chinese groups, and asked who had the “flower scour” in the group.
Health package received by international students. Picture provided by interviewee
The reporter inquired about several pharmacies in Beijing, all of which sold Lianhua Qingwen. Many salesmen mentioned that recently, many people came to our house to prepare several boxes.
“We will also introduce to our customers that Lianhuaqingwen is a patent Chinese medicine independently developed and produced by our country during the SARS period. Usually there is a flu or something. It’s also very useful to eat it in time. ” A drugstore clerk told reporters that when an old man came in the other day to buy Lianhuaqingwen, he couldn’t remember the name of the medicine, so he asked himself, “what medicine does Zhongnanshan say is useful?”
In March 25th, novel coronavirus pneumonia was treated by Zhong Nanshan in the Sino European epidemic prevention and exchange meeting. The rehabilitation rate of 284 patients treated with Lianhua Qingwen was 91.5%.
Novel coronavirus pneumonia, China Academy of engineering and President of Tianjin University of Traditional Chinese Medicine, Zhang Boli also introduced the main effect of Lianhua Qingwen is clearing away the toxin and detoxifying the lung and releasing heat from the lung, which has definite curative effect on the treatment of light and ordinary new crown pneumonia patients.
Domestic sales are stable, and foreign high prices are hard to find
According to the information disclosed by Yiling pharmaceutical, the manufacturer of Lianhua Qingwen, the company has gradually adjusted its production plan according to the market demand since March. At present, the normal production status has been restored, and the shortage of some terminals of Lianhua Qingwen in the domestic market has been alleviated.
“Lianhua Qingwen and other enterprises have been producing at full capacity, with relatively sufficient inventory and guaranteed market supply.” Cao Xuejun, deputy director of the Department of consumer goods industry of the Ministry of industry and information technology, said at a press conference on April 8 that up to now, Lianhua Qingwen capsule has a daily production capacity of 2 million boxes and a stock of 30 million boxes.
The staff of the offline drugstore also said that the supply of huaqingwen has been relatively stable recently, and they have not received the notice of price increase. The reporter inquired the online and offline drugstores and found that the 24 capsules sold at present are priced at 15-20 yuan per box, and the quantity is also sufficient.
However, on the cross-border e-commerce eBay platform, the price of products of the same specification has doubled several times, with an average price of about 70 yuan, and the delivery time is more than half a month or even longer.
Lianhua Qingwen capsule sold on eBay. screenshot
Due to its own particularity, drugs can not be bought and sold in other countries at will. To enter other countries and regions for sale, it is necessary to register according to the relevant local laws and regulations to obtain the listing license.
According to the information disclosed by Yiling pharmaceutical industry, in addition to mainland China, Hong Kong and Macao, Lianhua Qingwen only obtained listing approval in Brazil, Indonesia, Canada, Mozambique, Romania and Thailand.
Yiling pharmaceutical disclosed that the company is actively promoting the overseas registration of Lianhua Qingwen products. Taking the United States as an example, the second phase clinical research trial of Lianhuaqingwen carried out by FDA in the United States is still in normal progress, but the third phase clinical work needs to be carried out after the end of the second phase clinical work.
Not only can’t buy directly, Baiyi told reporters, under the current situation of the epidemic, even huaqingwen and other drugs, if sent by individuals from home, are difficult to reach abroad. Some overseas Chinese organizations are trying to get through diplomatic channels or logistics of embassies, but this is not easy.
For the overseas sales of Lianhua Qingwen, Yiling pharmaceutical replied: the company’s current sales of Lianhua Qingwen products in registered countries and regions are completed through local agents, who pay the company for goods at the agent price agreed with the company. The local sales price of drugs shall be determined by the agent according to the local actual situation.
Yiling Pharmaceutical Co., Ltd. doubled its share price and the founder’s wealth exceeded 10 billion yuan
On March 30, Yiling Pharmaceutical Co., Ltd. released the first quarter performance forecast of 2020. It is estimated that the net profit in the first quarter will be 430 million yuan to 460 million yuan, an increase of 50% to 60% over the previous year. The change in performance is mainly due to the sharp increase in operating revenue of Qingwen products in the first quarter compared with the same period last year.
Shijiazhuang Yiling pharmaceutical industry stepped up the production of Lianhua Qingwen capsule. Supplied by Hebei Provincial Drug Administration
With the support of many medical institutions and experts, the share price of Yiling pharmaceutical industry has reached a new high. From 12.43 yuan / share at the beginning of the year to 24.96 yuan / share at the closing on April 9, the increase has exceeded 100% since 2020.
With the share price and performance of Yiling Pharmaceutical Co., Ltd., Wu Yiling, the founder of Yiling Pharmaceutical Co., Ltd. and the academician of Chinese Academy of engineering known as “the richest academician of a shares”, will also have a substantial increase. According to Hurun global rich list 2020 released on February 26, 2020, the Wu Yiling family has 11 billion yuan of wealth.
Yiling pharmaceutical also said that the company will seize the opportunity brought by the further promotion of Lianhua Qingwen’s product popularity and do a good job in product promotion and sales under normal conditions